CRL vs LBRT

For growth investors, Charles River Laboratories International, Inc.

(CRL) is the stronger pick with -0. 9% revenue growth year-over-year, versus -7. 2% for Liberty Energy Inc. (LBRT). Liberty Energy Inc. (LBRT) offers the better valuation at 35. 6x trailing P/E (3480. 2x forward), making it the more compelling value choice. Analysts rate Charles River Laboratories International, Inc. (CRL) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Charles River Laboratories International, Inc.

is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Liberty Energy Inc.

(LBRT) delivered a total return of +132. 4%, compared to -46. 9% for Charles River Laboratories International, Inc. (CRL). Over 10 years, the gap is even starker: CRL returned +119. 2% versus LBRT's +94. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Liberty Energy Inc.

(LBRT) is the lower-risk stock at 1. 31β versus Charles River Laboratories International, Inc. 's 1. 52β — meaning CRL is approximately 16% more volatile than LBRT relative to the S&P 500. On balance sheet safety, Liberty Energy Inc. (LBRT) carries a lower debt/equity ratio of 42% versus 95% for Charles River Laboratories International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Charles River Laboratories International, Inc.

(CRL) is pulling ahead at -0. 9% versus -7. 2% for Liberty Energy Inc. (LBRT). On earnings-per-share growth, the picture is similar: Liberty Energy Inc. grew EPS -52. 4% year-over-year, compared to -1555. 0% for Charles River Laboratories International, Inc.. Over a 3-year CAGR, CRL leads at 0. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Liberty Energy Inc.

(LBRT) is the more profitable company, earning 3. 7% net margin versus -3. 6% for Charles River Laboratories International, Inc. — meaning it keeps 3. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRL leads at 12. 6% versus 2. 0% for LBRT. At the gross margin level — before operating expenses — CRL leads at 30. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Charles River Laboratories International, Inc.

(CRL) trades at 16. 4x forward P/E versus 3480. 2x for Liberty Energy Inc. — 3463. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRL: 12. 9% to $205. 43.

In this comparison, LBRT (1.

0% yield) pays a dividend. CRL does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Liberty Energy Inc.

(LBRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 0% yield). Charles River Laboratories International, Inc. (CRL) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LBRT: +94. 1%, CRL: +119. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CRL (Healthcare) and LBRT (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

LBRT pays a dividend while CRL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.